Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions
For G-lens purposes, we need 4 main aspects:
These are the persona's dimensions. It is true that some could be inferred from IPS directly or indirectly. But only some take part in the mandatory sections of IPS as can be seen below. For the ones not possible to be inferred from IPS, there are at least two paths:
Then, in both cases, observation can be coupled together as a document or message to be transmitted along with IPS.
check the diagram below for the alternative with questionnaire:
or the alternative without questionnaire:
Dimension | IPS | Terminology Examples | (validity) Questionnaire suggestion |
---|---|---|---|
Age | subject.birthDate | ||
Social Support/ family | N/A | 91663-5 Social support index [MOS Social Support Survey] | - 1.paper |
Sex | subject.gender | ||
WorkLife | N/A | PRAPARE - 2.paper | |
Smoking,ongoing | Social History | ||
Physical Activity | N/A | - 1.paper 2.questions | |
Organized | N/A | ||
Extrovert/introvert | N/A | ||
Emotional/Rational | N/A | ||
# diagnoses | ProblemList Section | ||
Chronic Afliction | secondary interpretation of Problem List | ||
# Medicines | MedicationSummary Section | ||
Health Advice received | N/A | ||
Concern Domains | N/A | ||
Share info Willingly | N/A | ||
Mood Level | N/A | 65457-4 First of all, how are you feeling today compared to your usual state | +- 1.paper 2.paper2 |
Autonomy | Functional Status | ||
Health Literacy | N/A | 85450-5 Health literacy and communication total | 1. European Health Literacy Survey Questionnaire (HLS-EU-Q) 2.example paper |
Digital Literacy | N/A | + 1.revision 1.paper | |
Tool Support Interest | N/A |
Pedro has a prescription of Pentasa (mesalamine), Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) which are contraindicated (kidney impact)